tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Spire Healthcare Non-Executive Director Jill Anderson Joins Croda International Board

Story Highlights
  • Spire Healthcare director Jill Anderson will join Croda International’s board as a non-executive director.
  • Her new blue-chip board role may enhance governance insight as Spire strengthens its UK healthcare position.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Spire Healthcare Non-Executive Director Jill Anderson Joins Croda International Board

Claim 50% Off TipRanks Premium

Spire Healthcare ( (GB:SPI) ) has provided an announcement.

Spire Healthcare has announced that non-executive director Jill Anderson has been appointed to the board of Croda International as a non-executive director, where she will also serve on the audit, nomination and remuneration committees from 12 January 2026. The additional blue-chip board role is likely to broaden Anderson’s external experience and networks, potentially enhancing governance insight at Spire as it maintains its position as a major independent provider of acute and specialist healthcare services across the UK.

The most recent analyst rating on (GB:SPI) stock is a Buy with a £2.75 price target. To see the full list of analyst forecasts on Spire Healthcare stock, see the GB:SPI Stock Forecast page.

Spark’s Take on GB:SPI Stock

According to Spark, TipRanks’ AI Analyst, GB:SPI is a Neutral.

Spire Healthcare’s overall stock score is driven by strong financial performance, particularly in revenue growth and operational efficiency. However, high leverage and low net profitability are concerns. Technical indicators suggest bearish momentum, and valuation metrics indicate potential overvaluation.

To see Spark’s full report on GB:SPI stock, click here.

More about Spire Healthcare

Spire Healthcare Group plc is a leading independent healthcare provider in the UK, operating 38 hospitals and more than 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. Working with over 8,700 consultants, it offers private GP and occupational health services to over 800 corporate clients, is the largest private provider of knee and hip operations by volume in the UK, and delivers a range of private and NHS mental health, musculoskeletal and dermatology services under the Vita Health Group brand. Its well-located, scalable hospitals have earned strong quality ratings from health inspectors, and the company is listed on the London Stock Exchange as a member of the FTSE 250.

Average Trading Volume: 1,500,446

Technical Sentiment Signal: Sell

Current Market Cap: £685.6M

For a thorough assessment of SPI stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1